These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3337910)

  • 21. Evidence for a nonoxidative mechanism of human natural killer (NK) cell cytotoxicity by using mononuclear effector cells from healthy donors and from patients with chronic granulomatous disease.
    Kay HD; Smith DL; Sullivan G; Mandell GL; Donowitz GR
    J Immunol; 1983 Oct; 131(4):1784-8. PubMed ID: 6311897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant interferon gamma augments phagocyte superoxide production and X-chronic granulomatous disease gene expression in X-linked variant chronic granulomatous disease.
    Ezekowitz RA; Orkin SH; Newburger PE
    J Clin Invest; 1987 Oct; 80(4):1009-16. PubMed ID: 2821069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An improved nitroblue tetrazolium test using phorbol myristate acetate-coated coverslips.
    Repine JE; Rasmussen B; White JG
    Am J Clin Pathol; 1979 May; 71(5):582-5. PubMed ID: 453076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improvement of a rapid screening test for chronic granulomatous disease.
    Iacobini M; Duse M; Di Coste A; Balducci L
    Int J Immunopathol Pharmacol; 2013; 26(3):807-8. PubMed ID: 24067482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reevaluation of cytochrome b and flavin adenine dinucleotide in neutrophils from patients with chronic granulomatous disease and description of a family with probable autosomal recessive inheritance of cytochrome b deficiency.
    Ohno Y; Buescher ES; Roberts R; Metcalf JA; Gallin JI
    Blood; 1986 Apr; 67(4):1132-8. PubMed ID: 3955232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of flow cytometric methods for diagnosis of chronic granulomatous disease variants under routine laboratory conditions.
    Emmendörffer A; Nakamura M; Rothe G; Spiekermann K; Lohmann-Matthes ML; Roesler J
    Cytometry; 1994 Sep; 18(3):147-55. PubMed ID: 7813334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An in-frame triplet deletion within the gp91-phox gene in an adult X-linked chronic granulomatous disease patient with residual NADPH-oxidase activity.
    Jendrossek V; Ritzel A; Neubauer B; Heyden S; Gahr M
    Eur J Haematol; 1997 Feb; 58(2):78-85. PubMed ID: 9111587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of human neutrophil oxidative metabolism and degranulation in vitro by nitroblue tetrazolium and vitamin E.
    Repine JE; Rao G; Beall GD; White JG
    Am J Pathol; 1978 Mar; 90(3):659-74. PubMed ID: 629327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prenatal diagnosis of chronic granulomatous disease.
    Matthay KK; Golbus MS; Wara DW; Mentzer WC
    Am J Med Genet; 1984 Apr; 17(4):731-9. PubMed ID: 6720741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flow cytometric analysis of the granulocyte respiratory burst: a comparison study of fluorescent probes.
    Vowells SJ; Sekhsaria S; Malech HL; Shalit M; Fleisher TA
    J Immunol Methods; 1995 Jan; 178(1):89-97. PubMed ID: 7829869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NBT reduction by exudate neutrophils in carriers of chronic granulomatous disease.
    Kowolik MJ; Raeburn JA
    J Infect; 1983 Jan; 6(1):96-7. PubMed ID: 6886451
    [No Abstract]   [Full Text] [Related]  

  • 32. Cytosolic free calcium changes induced by chemotactic peptide in neutrophils from patients with chronic granulomatous disease.
    Lew PD; Wollheim C; Seger RA; Pozzan T
    Blood; 1984 Jan; 63(1):231-3. PubMed ID: 6689950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of neutrophil-reduced pyridine nucleotide content following stimulation with phorbol myristate acetate and chemotactic factors.
    Van Epps DE; Bender JG; Steinkamp JA; Chenoweth DE
    J Leukoc Biol; 1985 Nov; 38(5):587-601. PubMed ID: 2995525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heterogeneity in chronic granulomatous disease detected with an improved nitroblue tetrazolium slide test.
    Meerhof LJ; Roos D
    J Leukoc Biol; 1986 Jun; 39(6):699-711. PubMed ID: 2423624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improvement of superoxide production in monocytes from patients with chronic granulomatous disease by recombinant cytokines.
    Jendrossek V; Peters AM; Buth S; Liese J; Wintergerst U; Belohradsky BH; Gahr M
    Blood; 1993 Apr; 81(8):2131-6. PubMed ID: 8386028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequency of the carrier state for X-linked chronic granulomatous disease among females with lupus erythematosus.
    Humbert JR; Fishman CB; Weston WL; DeArmey PA; Thoren CH
    Clin Genet; 1976 Jul; 10(1):16-20. PubMed ID: 949860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discoid lupus erythematosus-like skin lesions in a patient with autosomal recessive chronic granulomatous disease.
    Strate M; Brandrup F; Wang P
    Clin Genet; 1986 Sep; 30(3):184-90. PubMed ID: 3780033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolonged recombinant interferon-gamma therapy in chronic granulomatous disease: evidence against enhanced neutrophil oxidase activity.
    Woodman RC; Erickson RW; Rae J; Jaffe HS; Curnutte JT
    Blood; 1992 Mar; 79(6):1558-62. PubMed ID: 1312372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic Granulomatous Disease.
    Rawat A; Bhattad S; Singh S
    Indian J Pediatr; 2016 Apr; 83(4):345-53. PubMed ID: 26865172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional evaluation of human neutrophils. Is the bactericidal activity correlated with nitroblue tetrazolium reduction?
    Bellinati-Pires R; Carneiro-Sampaio MM; Colletto GM
    J Investig Allergol Clin Immunol; 1992; 2(3):146-53. PubMed ID: 1342894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.